If you liked this article you might like

Has Allergan's Pullback Run Its Course?
There You Have It; The Day's Trades: Doug Kass' Views
Cramer: Carl Icahn Was Right to Sell Apple at $95
Jim Cramer on Citigroup's Downgrade of Pfizer